Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Bimatoprost can cause excessive eyelash growth.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

A young girl developed unusually long eyelashes with a hair loss condition without other health issues or medication causes.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

An infant with complete hair loss was diagnosed with a genetic disorder affecting hair growth.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Bimatoprost helped a girl grow her eyelashes back quickly and without serious side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Patients with anxiety or depression report more severe alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.